Ads
related to: circulating tumor cell test- Precision Oncology
Finding Cancer's Fingerprint.
Learn More.
- Contact Us
Have Questions? Don’t Hesitate.
Contact Us Today.
- NRG1 Fusion
More Aggressive Than You Think.
Learn About NGR1 Today.
- Genomic Landscape
Genomics are Changing the Future
of Oncology. Learn More.
- Precision Oncology
invitae.com has been visited by 10K+ users in the past month
Search results
Natera to present new cancer test data at ASCO meeting By Investing.com
Investing.com· 6 days agoAmong the presentations, notable data from the CIRCULATE-Japan GALAXY study will be shared,...
New treatment may extend survival for people with advanced colon cancer
UPI· 5 hours agoPeople battling advanced colon cancers might have a new treatment option that could extend their...
Mercy Bioanalytics Pushing Forward with Plans to Market Ovarian Cancer Blood Test
GenomeWeb News· 1 day agoExtracellular vesicle diagnostics firm Mercy Bioanalytics is making progress in its plans to market and eventually garner US Food and Drug Administration approval for a novel ovarian cancer ...
Mammography is not banned in Switzerland, suspended in Canada
AFP via Yahoo News· 22 hours agoBreast cancer screening recommendations vary across different health systems, but claims that...
Insurance barriers hinder access to screening as colon cancer rates rise
UPI· 2 hours agoMore than 53,000 Americans are projected to die from colorectal cancer this year. Although...
CRISPR/Cas13a-based supersensitive circulating tumor DNA assay for detecting EGFR mutations in...
Nature· 2 days agoThe established HiCASE technique significantly enhances the detection of ultralow frequency mutated genes in ctDNA, promoting its application and translating basic research into clinical practice.
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
Benzinga· 6 days ago49 scheduled presentations will explore several types of cancer, as well as the next frontier of health equity NEW BRUNSWICK, N.J., May 23, 2024 /PRNewswire/ -- Clinicians and scientists from Rutgers Cancer Institute and
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoSALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies at the 2024 ASCO Annual Meeting. Three studies
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 7 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 7 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These